| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/06/2013 | CN102958932A Modulators of 5-HT receptors and methods of use thereof |
| 03/06/2013 | CN102958925A Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer |
| 03/06/2013 | CN102952146A Heterocyclic compound, organic light-emitting device, and flat display device |
| 03/06/2013 | CN102952143A Preparation method of tetraphenylporphin |
| 03/06/2013 | CN102952142A Synthesis method of three novel benzyloxy-containing porphyrin compounds |
| 03/06/2013 | CN102952141A Synthesis method of meso-tetra[4-(3,4-dimethoxybenzyloxy)phenyl]porphyrin |
| 03/06/2013 | CN102952140A Microwave synthesis method of three asymmetric porphyrins |
| 03/06/2013 | CN102952139A Trans-3a-fluoropyrrolidine[3,4-C]benzo cyclocompound and preparation method thereof |
| 03/06/2013 | CN102952138A Salts and polymorphic substances of pyrazolo pyrimidinone compound, pharmaceutical composition thereof, and preparation method and application thereof |
| 03/06/2013 | CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof |
| 03/06/2013 | CN102046201B Inhibitor of analgesic tolerance |
| 03/06/2013 | CN101817833B DPP-IV inhibitor |
| 03/06/2013 | CN101573363B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389721 Solubilized topoisomerase poisons |
| 03/05/2013 | US8389715 Method for forming cooperative binary ionic solids |
| 03/05/2013 | US8389532 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine |
| 03/05/2013 | US8389527 Substituted imidazopyridazines useful as kinase inhibitors |
| 03/05/2013 | US8389526 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| 03/05/2013 | US8389279 α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same |
| 03/05/2013 | CA2666258C Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 02/28/2013 | WO2013028832A2 Inhibitors of nedd8-activating enzyme |
| 02/28/2013 | WO2013028818A1 Pyrimido- pyridazinone compounds and use thereof |
| 02/28/2013 | WO2013028382A1 Benzopiperazine derivatives as cetp inhibitors |
| 02/28/2013 | WO2013027794A1 Novel compound and use thereof as pde10 inhibitor |
| 02/28/2013 | WO2013026516A1 Bicyclic heteroaromatic compounds |
| 02/28/2013 | WO2013026163A1 Hepatitis c inhibitor compounds |
| 02/28/2013 | WO2013026162A1 Hepatitis c inhibitor compounds |
| 02/28/2013 | WO2012158811A3 Purine monophosphate prodrugs for treatment of viral infections |
| 02/28/2013 | WO2012149157A3 Heterocyclic compounds for the inhibition of pask |
| 02/28/2013 | WO2012125544A3 Necroptosis inhibitors and methods of use therefor |
| 02/28/2013 | US20130053407 Pyrrolo [3,2-d] pyrimidin-3-yl derivatives used as activators of ampk |
| 02/28/2013 | US20130053403 Novel beta 3 adrenergic receptor agonists |
| 02/28/2013 | US20130053394 Pyrazolopyrimidine kinase inhibitors |
| 02/28/2013 | US20130053389 Certain chemical entities, compositions and methods |
| 02/28/2013 | US20130053388 Pyrazolopyrazine kinase inhibitors |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053376 Novel tyrosine kinase inhibitors |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053365 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053346 Pyrimido-pyridazinone compounds and methods of use thereof |
| 02/28/2013 | US20130053325 Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof |
| 02/28/2013 | US20130052734 Method for preparing regulatory dendritic cells |
| 02/28/2013 | US20130052138 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 02/28/2013 | US20130048955 Heterocyclic compound and organic light-emitting device containing the same |
| 02/28/2013 | CA2846231A1 Inhibitors of nedd8-activating enzyme |
| 02/28/2013 | CA2846187A1 Pyrimido-pyridazinone compounds and use thereof |
| 02/28/2013 | CA2846046A1 Bicyclic heteroaromatic compounds |
| 02/28/2013 | CA2845578A1 Pyrimidine pde10 inhibitors |
| 02/27/2013 | EP2560975A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes as vasopressin v1a receptor antagonists |
| 02/27/2013 | EP2560974A1 Pyrrazolopyridine derivatives |
| 02/27/2013 | EP2560973A1 Modulators of 5-ht receptors and methods of use thereof |
| 02/27/2013 | EP2560972A2 Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors |
| 02/27/2013 | EP2560656A2 Anti-viral compounds |
| 02/27/2013 | CN102947309A 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 02/27/2013 | CN102947308A Polymorphs of OSI-906 |
| 02/27/2013 | CN102947307A Novel antifungal 5,6-dihydro-4-[(difluoroethyl)phenyl]-4h-pyrrolo[1,2-a][1,4]benzodiazepine and 4-(difluoroethyl)phenyl-6h-pyrrolo[1,2-a][1,4]benzodiazepine derivatives |
| 02/27/2013 | CN102947305A Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | CN102947303A Bicyclic pyrimidinyl pyrazoles |
| 02/27/2013 | CN102942628A Co-production method for extracting bioactive substances from pig blood |
| 02/27/2013 | CN102942581A Spirocyclo-quaternary ammonium salt for supercapacitor and preparation method of spirocyclo-quaternary ammonium salt |
| 02/27/2013 | CN102942482A Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 02/27/2013 | CN102093367B Preparation method of spiro quaternary ammonium salt for organic electrolyte of super capacitor |
| 02/27/2013 | CN101918410B Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 02/27/2013 | CN101790533B Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 02/27/2013 | CN101522683B Pyraz0l0(l,5-A) (1, 3, 5) triazine and pyrazolo (1, 5-A) pyrimidine derivatives useful as protein kinase inhibitors |
| 02/26/2013 | US8383813 Fused pyrrolocarbazoles |
| 02/26/2013 | US8383812 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 02/26/2013 | US8383665 Immunomodulatory compositions |
| 02/26/2013 | US8383636 Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | US8383618 C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 02/26/2013 | CA2679991C Processes for making zilpaterol and salts thereof |
| 02/26/2013 | CA2542076C Substituted tricyclic compounds as protein kinase inhibitors |
| 02/21/2013 | WO2013025628A1 Janus kinase inhibitor compounds and methods |
| 02/21/2013 | WO2013025584A1 Inhibitors of human immunodeficiency virus replication |
| 02/21/2013 | WO2013024895A1 Tricyclic heterocyclic compounds and jak inhibitors |
| 02/21/2013 | WO2013024474A1 Polymorphs of preladenant |
| 02/21/2013 | WO2013024078A1 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | WO2013023511A1 Triazolopyrimidine derivative and preparation method and use thereof |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2012065139A3 Entpd5 inhibitors |
| 02/21/2013 | US20130046092 Switchable solvents and methods of use thereof |
| 02/21/2013 | US20130046091 Spiro-condensed indoline derivatives as pesticides |
| 02/21/2013 | US20130045980 Imidazopyridazinyl compounds |
| 02/21/2013 | US20130045965 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |
| 02/21/2013 | US20130045229 Anti-Viral Compounds |
| 02/21/2013 | US20130042916 Novel porphyrin complex and use thereof |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2841801A1 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | CA2841458A1 Tricyclic heterocyclic compounds and jak inhibitors |
| 02/20/2013 | EP2559693A1 Polycyclic compound |
| 02/20/2013 | EP2559687A1 Mesoionic pesticides |
| 02/20/2013 | EP2558469A1 Pyrrolopyrazinone inhibitors of kinases |
| 02/20/2013 | EP2558468A1 5, 7-substituted-imidazo [1, 2-c]pyrimidines as inhibitors of jak kinases |